查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585637

生物植入市场：按产品、管理方法和应用 - 全球预测 2025-2030

Biological Implants Market by Product (Allografts, Autografts, Xenografts), Mode of Administration (Injectable, Surgical), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年生物植入市场规模为337.3亿美元，预计2024年将达409亿美元，复合年增长率为21.36%，到2030年将达到1308.4亿美元。

生物植入是指植入体内以取代或补充自然功能的装置或组织。这些植入包括广泛的产品，包括整形外科植入、牙科植入、心血管植入和神经植入。对生物植入的需求不断增加是由于与老龄化相关的疾病、慢性疾病和事故的增加导致了对此类医疗干预的需求。最终用途多种多样，包括医院、诊所和专业研究中心。市场成长主要受到糖尿病、癌症、心血管疾病、整形外科疾病盛行率不断上升、医疗技术进步以及全球人口老化的影响。结合生物活性化合物和改善生物相容性的新材料代表了技术创新的重大机会。此外，数位健康技术（例如 3D 列印和生物列印）的集成为自订的、针对患者的植入开闢了新的扩展和适应途径。

主要市场统计
基准年[2023] 337.3亿美元
预测年份 [2024] 409亿美元
预测年份 [2030] 1308.4亿美元
复合年增长率（%） 21.36%

市场成长面临的主要限制和挑战包括植入式设备的高成本、复杂的监管核准流程以及可能导致不良免疫反应的生物相容性问题。这些因素可能会影响市场准入并延迟新产品的推出。创新应着重于开发具有成本效益的生产技术，透过仿生材料提高生物相容性，并利用奈米技术提高性能。公司应该投资与学术机构的研究合作伙伴关係，以保持在材料科学和再生医学进步的最前沿。市场竞争激烈，领先公司不断寻求透过合併、收购和合作来扩大产品系列。公司还应专注于定制以满足患者的特定需求并改善当地监管和报销条件。这项策略方针将有助于确保市场渗透并利用新兴经济体不断成长的商机。

市场动态：揭示快速发展的生物植入市场的关键市场洞察

供需的动态交互作用正在改变生物植入市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 精密植入手术的重大进展
    • 人口老化加剧，整形外科疾病、脊椎疾病等疾病的发生
    • 人们对美容植入的认识不断增强
  • 市场限制因素
    • 製造成本高
  • 市场机会
    • 3D列印和雷射技术等技术创新
    • 再生医学和组织工程的进展
  • 市场挑战
    • 报销不畅问题

波特五力：驾驭生物植入市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物植入市场的外部影响

外部宏观环境因素在塑造生物植入市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物植入市场的竞争格局

对生物植入市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物植入市场供应商的绩效评估

FPNV 定位矩阵是评估生物植入市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物植入市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物植入市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 精密植入手术的重大进展
      • 人口老化加剧，整形外科疾病、脊椎疾病等疾病增加
      • 提高人们对美容植入的认识
    • 抑制因素
      • 生产成本高
    • 机会
      • 3D列印和雷射技术等技术创新
      • 再生医学和组织工程的进展
    • 任务
      • 很少有退款问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物植入市场：副产品

  • 同种异体移植
  • 自体移植
  • 异种移植

第七章 生物植入市场管理方式

  • 可注射的
  • 外科手术

第八章生物植入市场：依应用分类

  • 心血管植入
  • 整形外科植入
  • 软组织植入物

第九章美洲生物植入市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太生物植入市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲生物植入市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Allografts.com
  • Alphatec Spine, Inc.
  • Altogen Labs
  • Auto Tissue Berlin GmbH
  • Baxter International, Inc.
  • BioPolymer GmbH & Co. KG
  • Citagenix Inc.
  • Conmed Corporation
  • CryoLife, Inc.
  • Edward LifeSciences Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin, LP by Leibinger family
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • NuVasive, Inc. by Globus Medical Inc
  • RTI Surgical, Inc.
  • Sanara MedTech, Inc.
  • Stryker Corporation
  • Surgenex LLC
  • TissueTech, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-ED54C46E8D5E

The Biological Implants Market was valued at USD 33.73 billion in 2023, expected to reach USD 40.90 billion in 2024, and is projected to grow at a CAGR of 21.36%, to USD 130.84 billion by 2030.

Biological implants refer to devices or tissues that are inserted into the body to replace or assist a natural function. These implants encompass a wide range of products, including orthopedic implants, dental implants, cardiovascular implants, and neural implants, among others. The growing necessity for biological implants stems from the rise in age-related conditions, chronic diseases, and accidents resulting in the need for such medical interventions. End-use applications are extensive, spanning across hospitals, clinics, and specialized research centers. Market growth is primarily influenced by the increasing prevalence of diabetes, cancer, cardiovascular diseases, and orthopedic disorders, paired with advancements in medical technology and an aging global population. New materials incorporating bioactive compounds and improved bio-compatibility present significant opportunities for innovation. Moreover, the integration of digital health technologies such as 3D printing and bioprinting for custom and patient-specific implants opens up new routes for expansion and adaptation.

KEY MARKET STATISTICS
Base Year [2023] USD 33.73 billion
Estimated Year [2024] USD 40.90 billion
Forecast Year [2030] USD 130.84 billion
CAGR (%) 21.36%

The major limitations and challenges facing market growth include the high cost of implantable devices, complex regulatory approval processes, and potential biocompatibility issues, which could lead to adverse immune responses. These factors can affect market accessibility and slow down the introduction of new products. Innovations should focus on developing cost-effective production techniques, enhancing biocompatibility through biomimetic materials, and leveraging nanotechnology for improved performances. Businesses should invest in research partnerships with academic institutions to stay at the forefront of material science and regenerative medicine advancements. The nature of the market is competitive, with major players constantly seeking to expand their product portfolios through mergers, acquisitions, and collaborations. Companies should also focus on addressing patient-specific needs through customization and improving regulatory and reimbursement landscapes across different regions. This strategic approach will ensure market penetration and capitalize on the expanding opportunities within emerging economies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Implants Market

The Biological Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant advancement in precise implant surgical procedures
    • Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
    • Rising awareness of cosmetic implants
  • Market Restraints
    • High production cost
  • Market Opportunities
    • Technological innovations such as 3D printing and laser technology
    • Advancements in regenerative medicine and tissue engineering
  • Market Challenges
    • Scant reimbursement issues

Porter's Five Forces: A Strategic Tool for Navigating the Biological Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Implants Market

A detailed market share analysis in the Biological Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Implants Market

A strategic analysis of the Biological Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Implants Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allografts.com, Alphatec Spine, Inc., Altogen Labs, Auto Tissue Berlin GmbH, Baxter International, Inc., BioPolymer GmbH & Co. KG, Citagenix Inc., Conmed Corporation, CryoLife, Inc., Edward LifeSciences Corporation, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KLS Martin, L.P. by Leibinger family, Medical Device Business Services, Inc., Medtronic PLC, NuVasive, Inc. by Globus Medical Inc, RTI Surgical, Inc., Sanara MedTech, Inc., Stryker Corporation, Surgenex LLC, TissueTech, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Allografts, Autografts, and Xenografts.
  • Based on Mode of Administration, market is studied across Injectable and Surgical.
  • Based on Application, market is studied across Cardiovascular Implants, Orthopedic Implants, and Soft Tissue Implants.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant advancement in precise implant surgical procedures
      • 5.1.1.2. Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
      • 5.1.1.3. Rising awareness of cosmetic implants
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations such as 3D printing and laser technology
      • 5.1.3.2. Advancements in regenerative medicine and tissue engineering
    • 5.1.4. Challenges
      • 5.1.4.1. Scant reimbursement issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Implants Market, by Product

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Autografts
  • 6.4. Xenografts

7. Biological Implants Market, by Mode of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Surgical

8. Biological Implants Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Implants
  • 8.3. Orthopedic Implants
  • 8.4. Soft Tissue Implants

9. Americas Biological Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biological Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biological Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Allografts.com
  • 3. Alphatec Spine, Inc.
  • 4. Altogen Labs
  • 5. Auto Tissue Berlin GmbH
  • 6. Baxter International, Inc.
  • 7. BioPolymer GmbH & Co. KG
  • 8. Citagenix Inc.
  • 9. Conmed Corporation
  • 10. CryoLife, Inc.
  • 11. Edward LifeSciences Corporation
  • 12. Integra LifeSciences Corporation
  • 13. Johnson & Johnson Services, Inc.
  • 14. KLS Martin, L.P. by Leibinger family
  • 15. Medical Device Business Services, Inc.
  • 16. Medtronic PLC
  • 17. NuVasive, Inc. by Globus Medical Inc
  • 18. RTI Surgical, Inc.
  • 19. Sanara MedTech, Inc.
  • 20. Stryker Corporation
  • 21. Surgenex LLC
  • 22. TissueTech, Inc.
  • 23. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL IMPLANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL IMPLANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOFT TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023